Literature DB >> 28389980

Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice.

Elisabetta Poluzzi1, Emanuel Raschi2, Igor Diemberger3, Fabrizio De Ponti2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28389980     DOI： 10.1007/s40264-017-0529-y

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  15 in total

Review 1.  The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions.

Authors:  M Pirmohamed; G P Aithal; E Behr; A Daly; D Roden
Journal:  Clin Pharmacol Ther       Date:  2011-06       Impact factor: 6.875

Review 2.  Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensity.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  Drug Discov Today       Date:  2016-10-04       Impact factor: 7.851

Review 3.  Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.

Authors:  Einar S Björnsson; Jay H Hoofnagle
Journal:  Hepatology       Date:  2015-12-21       Impact factor: 17.425

Review 4.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

Review 5.  Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.

Authors:  Peter J Schwartz; Raymond L Woosley
Journal:  J Am Coll Cardiol       Date:  2016-04-05       Impact factor: 24.094

6.  Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.

Authors:  Igor Diemberger; Giulia Massaro; Marta Cubelli; Daniela Rubino; Sara Quercia; Cristian Martignani; Matteo Ziacchi; Mauro Biffi; Alessandra Bernardi; Nicoletta Cacciari; Claudio Zamagni; Giuseppe Boriani
Journal:  Eur J Clin Pharmacol       Date:  2015-06-02       Impact factor: 2.953

7.  Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.

Authors:  M L De Bruin; M Pettersson; R H B Meyboom; A W Hoes; H G M Leufkens
Journal:  Eur Heart J       Date:  2005-01-06       Impact factor: 29.983

Review 8.  Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.

Authors:  Gerrit Frommeyer; Lars Eckardt
Journal:  Nat Rev Cardiol       Date:  2015-07-21       Impact factor: 32.419

9.  Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.

Authors:  Mariam Molokhia; Atul Pathak; Maryse Lapeyre-Mestre; Laetitia Caturla; Jean Louis Montastruc; Paul McKeigue
Journal:  Br J Clin Pharmacol       Date:  2008-07-15       Impact factor: 4.335

10.  Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Ariola Koci; Ugo Moretti; Edoardo Spina; Elijah R Behr; Miriam Sturkenboom; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606
View more
  6 in total

1.  Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies.

Authors:  Igor Diemberger; Emanuel Raschi; Gianluca Trifirò
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

2.  Antidepressants and the risk of arrhythmia in elderly affected by a previous cardiovascular disease: a real-life investigation from Italy.

Authors:  A Biffi; F Rea; L Scotti; A Mugelli; E Lucenteforte; A Bettiol; A Chinellato; G Onder; C Vitale; N Agabiti; G Trifirò; G Roberto; G Corrao
Journal:  Eur J Clin Pharmacol       Date:  2017-10-18       Impact factor: 2.953

3.  Association between QTc prolongation and mortality in patients with suspected poisoning in the emergency department: a transnational propensity score matched cohort study.

Authors:  Camilla Schade Hansen; Anton Pottegård; Ulf Ekelund; Helene Kildegaard Jensen; Jakob Lundager Forberg; Mikkel Brabrand; Annmarie Touborg Lassen
Journal:  BMJ Open       Date:  2018-07-07       Impact factor: 2.692

Review 4.  Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People.

Authors:  Carlotta Lunghi; Caterina Trevisan; Michele Fusaroli; Valentina Giunchi; Emanuel Raschi; Elisa Sangiorgi; Marco Domenicali; Stefano Volpato; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08

5.  GWAS of the electrocardiographic QT interval in Hispanics/Latinos generalizes previously identified loci and identifies population-specific signals.

Authors:  Raúl Méndez-Giráldez; Stephanie M Gogarten; Jennifer E Below; Jie Yao; Amanda A Seyerle; Heather M Highland; Charles Kooperberg; Elsayed Z Soliman; Jerome I Rotter; Kathleen F Kerr; Kelli K Ryckman; Kent D Taylor; Lauren E Petty; Sanjiv J Shah; Matthew P Conomos; Nona Sotoodehnia; Susan Cheng; Susan R Heckbert; Tamar Sofer; Xiuqing Guo; Eric A Whitsel; Henry J Lin; Craig L Hanis; Cathy C Laurie; Christy L Avery
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

Review 6.  The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia.

Authors:  Milo Gatti; Emanuel Raschi; Elisabetta Poluzzi; Cristian Martignani; Stefania Salvagni; Andrea Ardizzoni; Igor Diemberger
Journal:  Curr Heart Fail Rep       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.